دورية أكاديمية
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers
| العنوان: | Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers |
|---|---|
| المؤلفون: | Wu, J.Aff1, Aff2, Aff3, Liu, D., Offin, M.Aff5, Aff6, Lezcano, C., Torrisi, J. M., Brownstein, S., Hyman, D. M.Aff5, Aff6, Gounder, M. M.Aff5, Aff6, Abida, W.Aff5, Aff6, Drilon, A.Aff5, Aff6, Aff12, Harding, J. J.Aff5, Aff6, Sullivan, R. J., Janku, F., Welsch, D., Varterasian, M., Groover, A., Li, B. T.Aff5, Aff6, Aff12, IDs10637020010359_cor17, Lacouture, M. E.Aff1, Aff8, Aff13, IDs10637020010359_cor18 |
| المصدر: | Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 39(3):785-795 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 01676997 15730646 |
|---|---|
| DOI: | 10.1007/s10637-020-01035-9 |